Prostate Cancer - Results from #25640

Therapeutic strategies for bone metastases and their clinical sequelae in prostate cancer - Abstract June 14, 2012

The influence of distress on knowledge transfer for men newly diagnosed with prostate cancer - Abstract June 14, 2012

A survival score for patients with metastatic spinal cord compression from prostate cancer - Abstract June 13, 2012

Intermittent androgen deprivation as therapy for androgen-sensitive prostate cancer : Sense or nonsense? - Abstract June 13, 2012

Prostate-specific antigen use among men without prostate cancer in France (2008-2010) - Abstract June 13, 2012

Does pelvic lymph node dissection improve the biochemical relapse-free survival in low-risk prostate cancer patients treated by laparoscopic radical prostatectomy? - Abstract June 13, 2012

Experimental investigation of the cytotoxicity of medium-borne signals in human prostate cancer cell line - Abstract June 13, 2012

High-grade prostate cancer: Favorable results in the modern era regardless of initial treatment - Abstract June 13, 2012

Findings in 12-core transrectal ultrasound-guided prostate needle biopsy that predict more advanced cancer at prostatectomy: Analysis of 388 biopsy-prostatectomy pairs - Abstract June 13, 2012

Prognostic role of serum parathyroid hormone levels in advanced prostate cancer patients undergoing zoledronic acid administration - Abstract June 13, 2012

Castration-resistant prostate cancer: Systemic therapy in 2012 - Abstract June 13, 2012

Strategy in advanced castration-resistant prostate cancer - Abstract June 13, 2012

[(18) F]fluoromethylcholine (FCH) positron emission tomography/computed tomography (PET/CT) for lymph node staging of prostate cancer: A prospective study of 210 patients - Abstract June 13, 2012

Ability of C-reactive protein to complement multiple prognostic classifiers in men with metastatic castration resistant prostate cancer receiving docetaxel-based chemotherapy - Abstract June 13, 2012

Accuracy of endorectal magnetic resonance imaging (MRI) and dynamic contrast enhanced-MRI (DCE-MRI) in the preoperative local staging of prostate cancer - Abstract June 12, 2012

Beyond PSA: Are new prostate cancer biomarkers of potential value to New Zealand doctors? - Abstract June 12, 2012

Variability of the urological clinical practice in prostate cancer in Spain - Abstract June 12, 2012

Evaluation of the respiratory prostate motion with four-dimensional computed tomography scan acquisitions using three implanted markers - Abstract June 12, 2012

Increasing the risk of late rectal bleeding after high-dose radiotherapy for prostate cancer: The case of previous abdominal surgery. Results from a prospective trial - Abstract June 12, 2012

Optimization of treatment planning parameters used in tomotherapy for prostate cancer patients - Abstract June 12, 2012

Page 1283 of 1437